Covid-19 pandemic: Omicron likely to protect against Delta infections

Global Covid-19 cases hit a daily record on Monday

nasal swab, Covid-19, Omicron, Covid Testing
A nasal swab test being performed in Los Angeles, California. The WHO warned that the Omicron variant could lead to overwhelmed healthcare systems (Photo: Reuters)
Agencies
2 min read Last Updated : Dec 28 2021 | 11:43 PM IST
Infection with the Omicron coronavirus variant can also strengthen immunity against the earlier Delta strain, reducing the risk of severe disease, according to a paper released by South African scientists. 

While Omicron has been shown to be highly transmissible and can evade some antibodies, after two weeks of getting symptoms immunity to subsequent infections from the strain rose 14-fold, according to the authors led by Alex Sigal and Khadija Khan of the Durban, South Africa-based Africa Health Research Institute. A smaller improvement was found against Delta, they said. 

“If we are lucky, Omicron is less pathogenic, and this immunity will help push Delta out,” said Sigal. The latest findings suggest the likelihood of someone infected with Omicron being reinfected by Delta is limited.

Meanwhile, global Covid-19 cases hit a daily record on Monday. The more than 1.44 million worldwide infections smashed the prior record after factoring out a day in December 2020 when Turkey backdated a significant number of cases. A more conservative gauge — the seven-day rolling average that smooths out one-time fluctuations and holiday reporting irregularities — is also at a record level, due to a tidal wave of Omicron infections.


France made working from home compulsory three days a week to contain the spread of the Omicron variant. Workers that have the option to stay away from the office must do so a minimum of three days and if possible four days, Prime Minister Jean Castex said.

The US Centers for Disease Control and Prevention cut the recommended isolation restrictions for Americans who catch the coronavirus to five days from 10 days, and similarly shortened the time that close contacts need to quarantine.

The Asian Development Bank said global remittances were likely to grow by $34 billion this year and about $31 billion in 2022, reversing last year’s decline, as economies recovered from the impact of the pandemic. Estimated remittance growth of 4.8 per cent globally this year reflects a comparison to last year’s low base.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Coronavirus VaccineCoronavirus TestsDelta

Next Story